These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2613153)

  • 1. [Identification of the Goodpasture antigen. Discovery of a further autoantibody-antigen system].
    Weber M
    Fortschr Med; 1989 Sep; 107(28):591. PubMed ID: 2613153
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on the nature of the Goodpasture antigen using a basement membrane-producing mouse tumour.
    Wick G; Timpl R
    Clin Exp Immunol; 1980 Mar; 39(3):733-8. PubMed ID: 6247110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Goodpasture target antigens in basement membranes of human glomeruli, lung, and placenta.
    Weber M; Köhler H; Manns M; Baum HP; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1987 Feb; 67(2):262-9. PubMed ID: 3608225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
    Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
    Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraglomerular distribution of immunoreactive Goodpasture antigen.
    Cashman SJ; Pusey CD; Evans DJ
    J Pathol; 1988 May; 155(1):61-70. PubMed ID: 3288737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goodpasture syndrome: molecular architecture and function of basement membrane antigen.
    Hudson BG; Wieslander J; Wisdom BJ; Noelken ME
    Lab Invest; 1989 Sep; 61(3):256-69. PubMed ID: 2671489
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
    Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
    J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new concept for ultrasensitive fluorescence measurements of molecules in solution and membrane: 2. The individual immune molecule.
    Földes-Papp Z; Demel U; Tilz GP
    J Immunol Methods; 2004 Mar; 286(1-2):13-20. PubMed ID: 15087218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a non-Goodpasture autoantibody to type IV collagen.
    Johansson C; Butkowski R; Swedenborg P; Alm P; Wieslander J
    Nephrol Dial Transplant; 1993; 8(11):1205-10. PubMed ID: 8302456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nosology and classification of autoimmune pulmonary disorders].
    Molina C; Tourreau A
    Poumon Coeur; 1973; 29(3):275-6 passim. PubMed ID: 4132598
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmunity and glomerulonephritis.
    Lockwood CM; Bowman C; Bakes D; Pressey A; Dash A
    Adv Nephrol Necker Hosp; 1987; 16():291-306. PubMed ID: 3101428
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity of circulating and tissue-bound autoantibodies in Goodpasture syndrome.
    Kalluri R; Melendez E; Rumpf KW; Sattler K; Müller GA; Strutz F; Neilson EG
    Proc Assoc Am Physicians; 1996 Mar; 108(2):134-9. PubMed ID: 8705733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies.
    Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
    J Am Soc Nephrol; 2007 Apr; 18(4):1338-43. PubMed ID: 17329569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Goodpasture syndrome. Progress in immunopathogenesis, diagnosis and therapy].
    Weber M; Marx M; Merkel F
    Internist (Berl); 1995 Mar; 36(3):227-35. PubMed ID: 7737815
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
    Ooi JD; Holdsworth SR; Kitching AR
    J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the Goodpasture antigen, alpha 3(IV) NC1, and four other NC1 domains of type IV collagen, by amino-terminal sequence analysis of human glomerular basement membrane separated by two-dimensional electrophoresis.
    Derry CJ; Pickering M; Baker C; Pusey CD
    Exp Nephrol; 1994; 2(4):249-56. PubMed ID: 7520821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational diversity of the Goodpasture antigen, the noncollagenous-1 domain of the alpha3 chain of collagen IV.
    Calvete JJ; Revert F; Blanco M; Cervera J; Tárrega C; Sanz L; Revert-Ros F; Granero F; Pérez-Payá E; Hudson BG; Saus J
    Proteomics; 2006 Apr; 6 Suppl 1():S237-44. PubMed ID: 16534749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological properties of the human Goodpasture target antigen.
    Weber M; Meyer zum Büschenfelde KH; Köhler H
    Clin Exp Immunol; 1988 Nov; 74(2):289-94. PubMed ID: 3224445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathologic aspects of lung disease.
    Vazquez JJ
    Arch Intern Med; 1970 Sep; 126(3):471-4. PubMed ID: 5311154
    [No Abstract]   [Full Text] [Related]  

  • 20. [Goodpasture's syndrome].
    Ratajski W; Laskowski S; Koppicz M
    Pol Tyg Lek; 1974 Jan; 29(4):157-60. PubMed ID: 4132233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.